Cardiol Therapeutics Inc. (CRDL)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.27
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
31.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 15.35M | $20.0M | 17.65% | +15.14M | 2026-03-31 |
| Tejara Capital Ltd | 5.13M | $6.0M | 5.90% | -- | 2026-03-31 |
| Ikarian Capital, LLC | 2.73M | $3.0M | 3.13% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 896.5K | $1.0M | 1.03% | +807.7K | 2026-03-31 |
| BOOTHBAY FUND MANAGEMENT, LLC | 794.9K | $1.0M | 0.91% | -- | 2026-03-31 |
| INTEGRITY ALLIANCE, LLC. | 465.0K | -- | 0.53% | +30.0K | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 332.4K | -- | 0.38% | +3.9K | 2026-03-31 |
| MORGAN STANLEY | 250.4K | -- | 0.29% | -94.0K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 229.8K | -- | 0.26% | -- | 2026-03-31 |
| JANE STREET GROUP, LLC | 172.8K | -- | 0.20% | +89.9K | 2026-03-31 |